Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Silo Pharma (SILO) Income from Non-Controlling Interests (2022 - 2023)

Historic Income from Non-Controlling Interests for Silo Pharma (SILO) over the last 3 years, with Q2 2023 value amounting to $1.0 million.

  • Silo Pharma's Income from Non-Controlling Interests changed N/A to $1.0 million in Q2 2023 from the same period last year, while for Jun 2023 it was $4.6 million, marking a year-over-year change of. This contributed to the annual value of $3.9 million for FY2022, which is N/A changed from last year.
  • As of Q2 2023, Silo Pharma's Income from Non-Controlling Interests stood at $1.0 million.
  • Silo Pharma's 5-year Income from Non-Controlling Interests high stood at $1.7 million for Q4 2022, and its period low was $906396.0 during Q1 2023.